Retail & Wholesale » Retail | China NT Pharma Group Co. Ltd.

China NT Pharma Group Co. Ltd. | Mutual Funds

Mutual Funds that own China NT Pharma Group Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Small Cap Series
5,549,000
0.35%
456,500
0.02%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
4,305,000
0.27%
476,000
0%
04/30/2018
iShares Core MSCI Total International Stock ETF
1,923,000
0.12%
0
0%
09/05/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
1,909,500
0.12%
0
0%
09/05/2018
CREF Stock Account
1,092,500
0.07%
0
0%
03/31/2018
SPDR S&P Emerging Markets Small Cap ETF
922,400
0.06%
0
0.04%
09/06/2018
SPDR S&P Emerging Markets ETF
818,100
0.05%
0
0.01%
09/06/2018
iShares III Plc - MSCI Emerging Markets Small Cap
577,000
0.04%
0
0.03%
09/05/2018
iShares MSCI Emerging Markets Small Cap ETF
464,000
0.03%
0
0.03%
09/05/2018
DFA TA World (ex-US) Core Equity Portfolio
211,500
0.01%
0
0%
04/30/2018

About China NT Pharma Group Co.

View Profile
Address
Unit 1505, 15th Floor
Hong Kong
Hong Kong
Employees -
Website http://www.ntpharma.com
Updated 07/08/2019
China NT Pharma Group Co., Ltd. is a pharmaceutical company, which engages in the provision of distribution, promotion, manufacturing as well as research and development of pharmaceuticals and vaccines. It operates through the following segments: Proprietary Products Production and Sales, and Miacalcic. The Proprietary Products Production and Sales segment engages in the production and sales of the company branded products and generic drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.